Prostate-specific membrane antigen positron emission tomography/computed tomography as a potential tool to assess and guide salivary gland irradiation
•PSMA PET/CT allows visualisation of salivary glands with good spatial and contrast resolution.•Evaluable glands include minor and less well-known gland locations.•PSMA PET/CT can visualise damage to salivary glands from external beam radiotherapy.•PSMA PET/CT has the potential to guide optimisation...
Gespeichert in:
Veröffentlicht in: | Physics and imaging in radiation oncology 2019-01, Vol.9, p.65-68 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •PSMA PET/CT allows visualisation of salivary glands with good spatial and contrast resolution.•Evaluable glands include minor and less well-known gland locations.•PSMA PET/CT can visualise damage to salivary glands from external beam radiotherapy.•PSMA PET/CT has the potential to guide optimisation of radiotherapy to the head and neck.•The potential benefit of PSMA PET/CT is to avoid salivary gland toxicity and preserve quality of life.
Evaluation of salivary gland damage after head and neck radiotherapy (RT) is difficult with current tools, such as subjective patient-reported outcome measures. We demonstrate the use of prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) as an objective non-invasive tool to visualize damage to salivary glands resulting from RT. In three clinical cases, the PSMA-ligand distribution correlates to the RT dose distribution including intra-gland dose gradients and matches patient-reported toxicity, suggesting a dose-response relation. These findings support further exploration of PSMA PET/CT to guide and evaluate RT, with the ultimate aim to reduce salivary gland toxicity. |
---|---|
ISSN: | 2405-6316 2405-6316 |
DOI: | 10.1016/j.phro.2019.02.004 |